27.25
Palatin Technologies Inc. stock is traded at $27.25, with a volume of 43,224.
It is up +10.46% in the last 24 hours and up +146.83% over the past month.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Its drug development programs also include melanocortin receptor system program, such as PL-8177, a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, a preclinical development candidate for treating ocular inflammation, as well as melanocortin receptor 4 peptides and orally-active small molecules to treat genetic metabolic and obesity disorders. In addition, the company develops natriuretic peptide receptor systems comprising PL3994, a natriuretic peptide receptor-A agonist, which has completed Phase I clinical study for the treatment of cardiovascular indications; and PL-5028, a dual natriuretic peptide receptor A and C agonist that is in preclinical development for cardiovascular diseases, such as reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.
See More
Previous Close:
$24.67
Open:
$26
24h Volume:
43,224
Relative Volume:
0.02
Market Cap:
$46.40M
Revenue:
$7.10M
Net Income/Loss:
$-31.59M
P/E Ratio:
-10.44
EPS:
-2.61
Net Cash Flow:
$-26.75M
1W Performance:
+18.48%
1M Performance:
+146.83%
6M Performance:
+28,859%
1Y Performance:
+3,084%
Palatin Technologies Inc. Stock (PTN) Company Profile
Name
Palatin Technologies Inc.
Sector
Industry
Phone
609-495-2200
Address
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Compare PTN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PTN
Palatin Technologies Inc.
|
27.25 | 42.00M | 7.10M | -31.59M | -26.75M | -2.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-03-25 | Initiated | Alliance Global Partners | Buy |
| Jun-05-15 | Reiterated | Canaccord Genuity | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| May-23-12 | Initiated | Noble Financial | Buy |
| Jan-23-07 | Initiated | Next Generation | Buy |
Palatin Technologies Inc. Stock (PTN) Latest News
JANUS HENDERSON GROUP PLC Acquires Shares in Palatin Technologies Inc - GuruFocus
Palatin Techs (PTN) Receives 'Buy' Rating from Laidlaw & Co. | P - GuruFocus
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals - TipRanks
Laidlaw initiates coverage on Palatin Technologies stock with Buy rating By Investing.com - Investing.com Nigeria
Laidlaw initiates coverage on Palatin Technologies stock with Buy rating - Investing.com
Why Are Palatin Technologies (PTN) Shares Spiking After-Hours? - Benzinga
Critical Survey: NexImmune (NASDAQ:NEXI) and Palatin Technologies (PINK:PTNT) - Defense World
Palatin Technologies (PINK:PTNT) Stock Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Can Palatin Technologies Inc. (PTN) stock attract ESG investmentsMarket Performance Recap & Safe Entry Momentum Tips - Newser
Why analysts raise outlook for Palatin Technologies Inc. (PTN) stockMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser
Is Palatin Technologies Inc. (PTN) stock overpriced at current multiplesQuarterly Trade Summary & Real-Time Sentiment Analysis - Newser
Palatin Technologies Inc (PTN) Stock News & Articles - 24/7 Wall St.
Palatin initiated with a Buy at Alliance Global - TipRanks
Lucid Capital Markets initiates Palatin Technologies stock with Buy rating By Investing.com - Investing.com Canada
Lucid Capital Markets initiates Palatin Technologies stock with Buy rating - Investing.com
Will Palatin Technologies Inc. (PTN) stock benefit from sector leadership2025 Trading Volume Trends & High Accuracy Swing Trade Signals - Newser
Palatin Technologies, Inc. (PTN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Why Palatin Technologies Inc. (PTN) stock could break out in 2025Dollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Can Palatin Technologies Inc. (PTN) stock stage a strong rebound this quarterNew Guidance & Long-Term Safe Investment Plans - Newser
Palatin Technologies (PINK:PTNT) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World
Palatin Technologies Inc trading halted, volatility trading pause - MSN
Biotech Alert: Searches spiking for these stocks today - TipRanks
Is Palatin Technologies Inc (PTN) positioned for future growth? - Setenews
Palatin Technologies Inc trading resumes - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Palatin Technologies, Inc. (PTN) Q2 FY2025 earnings call transcript - Yahoo Finance
What drives Palatin Technologies Inc PTN stock priceStock Watchlist Updates & Free Risk Assessment and Control - earlytimes.in
Why ETFs are accumulating Palatin Technologies Inc. (PTN) stock2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
How Palatin Technologies Inc. (PTN) stock trades in high volatilityEarnings Performance Report & Growth-Oriented Investment Plans - newser.com
EBIT per share of Palatin Technologies, Inc. – AMEX:PTN - TradingView
CapEx per share of Palatin Technologies, Inc. – AMEX:PTN - TradingView
CapEx per share of Palatin Technologies, Inc. – BOATS:PTN - TradingView
COO Wills Acquires 603 Of Palatin Technologies Inc [PTN] - TradingView
Palatin Technologies (OTCQB: PTNT) hits €5.5M milestone, eligible for up to €278M - Stock Titan
Working capital per share of Palatin Technologies, Inc. – AMEX:PTN - TradingView
Palatin Technologies Inc. Stock (PTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):